Hematological disorders deal with blood related diseases and generally affect the quantity or functionality of the cells or proteins present in the blood. Some blood disorders result in the increase of the number of cells in blood such as anemia, leukopenia while other cause the number of blood cells to decrease such as leukocytosis and thrombocytosis. The modern approach of using point of care diagnostics, cytometry techniques in hematological disorder diagnosis have outpaced the traditional methods because they can be used even in the absence of healthcare personnel and in extreme conditions.

๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ :

The key companies operating in the global drugs and diagnostics for hematological disorders market include Abbot Laboratories, Pfizer, Amgen, Beckman Coulter, Mindray Medical International Biogen Idec, Roche Diagnostics A/S, Biorad Laboratories, Eli Lilly and Company, Sysmex, Bristol-Myers, Siemens AG, Horbia, and Nihon Kohden,

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/1670

๐Š๐„๐˜ ๐…๐ˆ๐๐ƒ๐ˆ๐๐†๐’ ๐Ž๐… ๐“๐‡๐„ ๐’๐“๐”๐ƒ๐˜

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global drugs and diagnostics for hematological disorders market.
  • Geographically, drugs and diagnostics for hematological disorders market is analyzed based on various regions such as North America, Europe, Asia-Pacific and LAMEA.
  • This study evaluating competitive landscape and value chain has been taken into account to help in understanding the competitive environment across the geographies.
  • This report entails the detailed quantitative analysis of the current market and estimations through 2014-2022, which assists in identifying the prevailing market opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the global drugs and diagnostics for hematological disorders market is provided.

๐…๐จ๐ซ ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/1670

The report segments the drugs and diagnostics for hematological disorders market on the basis of product type, end user and by geography. According to the product type, market is segmented into analyzers and reagents. On the basis of end-user, the market is segregated into academic and research institutes, point-of-care testing, patient self-testing, biopharmaceutical industries, hospitals and clinical laboratories. Geographic breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific and LAMEA.

Major key players of the market have adopted product launch as their key strategy. Beckmann coulter, a wholly owned subsidiary of Danaher Corporation launched DxH 500 hematology analyzer on Feb 10, 2016. The analyzer delivers high quality result for blood cell count parameters. Moreover, Sysmex also launched new automated hematology analyzer XN-L series in 2014 which and is a compact instrument and conducts automated reticulocyte analysis using flow cytometry method.

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.


David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

Leave a comment

Your email address will not be published.